Yat Sun Or

Enanta Pharmaceuticals

Senior Vice President, Research & Development and Chief Scientific Officer

Overview

Yat Sun Or made an average of $1.2M in compensation at Enanta Pharmaceuticals from 2011 to 2018.

Annual data

2018

In 2018, Yat Sun Or earned a total compensation of $1.5M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking4,739 out of 8,741
Percentile45.8%

Yat Sun Or's 2018 compensation ranked 4,739th out of 8,741 executive pay records tracked by us this year.

Or earned more than 45.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking354 out of 626
Percentile43.5%

In the industry group of Drugs, Or's pay ranked 354th out of 626 executive pay records tracked by us in 2018.

Or earned more than 43.5% of executives in this group.

Non-Equity Incentive Plan$171,072
Option Awards$630,855
Salary$427,950
Stock Awards$275,275
Other$18,851
Total$1,524,003

Or received $630.9K in option awards, which accounts for 41.39% of total compensation.

Or also received $171.1K in non-equity incentive plan, $428K in salary, $275.3K in stock awards and $18.9K in other compensation.

2017

In 2017, Yat Sun Or earned a total compensation of $1.8M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking5,622 out of 13,227
Percentile57.5%

Yat Sun Or's 2017 compensation ranked 5,622nd out of 13,227 executive pay records tracked by us this year.

Or earned more than 57.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking468 out of 1,405
Percentile66.7%

In the industry group of Drugs, Or's pay ranked 468th out of 1,405 executive pay records tracked by us in 2017.

Or earned more than 66.7% of executives in this group.

Bonus$121,255
Non-Equity Incentive Plan$48,700
Option Awards$599,585
Salary$400,975
Stock Awards$574,369
Other$18,551
Total$1,763,435

Or received $599.6K in option awards, which accounts for 34.00% of total compensation.

Or also received $121.3K in bonus, $48.7K in non-equity incentive plan, $401K in salary, $574.4K in stock awards and $18.6K in other compensation.

2016

In 2016, Yat Sun Or earned a total compensation of $1.3M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking6,707 out of 13,877
Percentile51.7%

Yat Sun Or's 2016 compensation ranked 6,707th out of 13,877 executive pay records tracked by us this year.

Or earned more than 51.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking612 out of 1,472
Percentile58.4%

In the industry group of Drugs, Or's pay ranked 612th out of 1,472 executive pay records tracked by us in 2016.

Or earned more than 58.4% of executives in this group.

Bonus$114,633
Non-Equity Incentive Plan$48,078
Option Awards$654,806
Salary$386,069
Stock Awards$122,428
Other$15,857
Total$1,341,871

Or received $654.8K in option awards, which accounts for 48.80% of total compensation.

Or also received $114.6K in bonus, $48.1K in non-equity incentive plan, $386.1K in salary, $122.4K in stock awards and $15.9K in other compensation.

2015

In 2015, Yat Sun Or earned a total compensation of $1.7M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking5,338 out of 13,574
Percentile60.7%

Yat Sun Or's 2015 compensation ranked 5,338th out of 13,574 executive pay records tracked by us this year.

Or earned more than 60.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking556 out of 1,484
Percentile62.5%

In the industry group of Drugs, Or's pay ranked 556th out of 1,484 executive pay records tracked by us in 2015.

Or earned more than 62.5% of executives in this group.

Bonus$151,030
Option Awards$1,078,330
Salary$374,825
Stock Awards$96,762
Other$15,706
Total$1,716,653

Or received $1.1M in option awards, which accounts for 62.82% of total compensation.

Or also received $151K in bonus, $374.8K in salary, $96.8K in stock awards and $15.7K in other compensation.

2014

In 2014, Yat Sun Or earned a total compensation of $1.4M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking6,042 out of 12,876
Percentile53.1%

Yat Sun Or's 2014 compensation ranked 6,042nd out of 12,876 executive pay records tracked by us this year.

Or earned more than 53.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking554 out of 1,310
Percentile57.7%

In the industry group of Drugs, Or's pay ranked 554th out of 1,310 executive pay records tracked by us in 2014.

Or earned more than 57.7% of executives in this group.

Bonus$148,863
Option Awards$877,954
Salary$365,251
Other$11,369
Total$1,403,437

Or received $878K in option awards, which accounts for 62.56% of total compensation.

Or also received $148.9K in bonus, $365.3K in salary and $11.4K in other compensation.

2013

In 2013, Yat Sun Or earned a total compensation of $992.8K as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking6,537 out of 11,965
Percentile45.4%

Yat Sun Or's 2013 compensation ranked 6,537th out of 11,965 executive pay records tracked by us this year.

Or earned more than 45.4% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking492 out of 1,095
Percentile55.1%

In the industry group of Drugs, Or's pay ranked 492nd out of 1,095 executive pay records tracked by us in 2013.

Or earned more than 55.1% of executives in this group.

Bonus$143,174
Option Awards$501,973
Salary$343,255
Other$4,439
Total$992,841

Or received $502K in option awards, which accounts for 50.56% of total compensation.

Or also received $143.2K in bonus, $343.3K in salary and $4.4K in other compensation.

2012

In 2012, Yat Sun Or earned a total compensation of $606.1K as Senior Vice President, Research Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking7,835 out of 10,956
Percentile28.5%

Yat Sun Or's 2012 compensation ranked 7,835th out of 10,956 executive pay records tracked by us this year.

Or earned more than 28.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking533 out of 850
Percentile37.3%

In the industry group of Drugs, Or's pay ranked 533rd out of 850 executive pay records tracked by us in 2012.

Or earned more than 37.3% of executives in this group.

Bonus$136,569
Option Awards$143,704
Salary$321,415
Other$4,439
Total$606,127

Or received $321.4K in salary, which accounts for 53.03% of total compensation.

Or also received $136.6K in bonus, $143.7K in option awards and $4.4K in other compensation.

2011

In 2011, Yat Sun Or earned a total compensation of $503.8K as Senior Vice President, Research Development and Chief Scientific Officer at Enanta Pharmaceuticals.

Ranking7,645 out of 10,045
Percentile23.9%

Yat Sun Or's 2011 compensation ranked 7,645th out of 10,045 executive pay records tracked by us this year.

Or earned more than 23.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking492 out of 705
Percentile30.2%

In the industry group of Drugs, Or's pay ranked 492nd out of 705 executive pay records tracked by us in 2011.

Or earned more than 30.2% of executives in this group.

Bonus$105,519
Option Awards$80,679
Salary$313,208
Other$4,421
Total$503,826

Or received $313.2K in salary, which accounts for 62.17% of total compensation.

Or also received $105.5K in bonus, $80.7K in option awards and $4.4K in other compensation.